Description

Thyrocare Technologies Limited announces bonus issue at 2:1 ratio with deemed allotment date December 1, 2025 and trading commencement December 2, 2025.

Summary

Thyrocare Technologies Limited (Scrip Code: 539871) has submitted details of its bonus issue to BSE, confirming issuance of 10,61,07,794 equity shares at a 2:1 ratio. The deemed date of allotment is December 1, 2025, with shares to be credited to deposition systems by 12:00 PM on the same day. Trading of bonus shares will commence on December 2, 2025. The company has obtained in-principle approval from BSE and complied with SEBI Circular SEBI/CIR/CFD/PoD/2024/122.

Key Points

  • Bonus ratio: 2:1 (2 bonus shares for every 1 existing share)
  • Total bonus shares to be issued: 10,61,07,794 equity shares
  • Face value: ₹10 per share
  • Deemed date of allotment: December 1, 2025 (T+1 day)
  • Effective listing date: December 2, 2025 (T+2 day)
  • Distinctive number range: 54012798 to 160120591
  • ISIN: INE594H01019
  • Record date intimation filed: November 16, 2025
  • In-principle approval from BSE obtained
  • Scrutinizer’s report uploaded 3 working days before record date

Regulatory Changes

No regulatory changes announced. The circular confirms compliance with SEBI Circular SEBI/CIR/CFD/PoD/2024/122 dated September 16, 2024, regarding timelines for bonus share credit and trading availability.

Compliance Requirements

  • Company undertakes to credit bonus shares to depository system by 12:00 PM on December 1, 2025 (T+1 day)
  • Bonus equity shares must be available for trading at Beginning of Day (BOD) on December 2, 2025 (T+2 day)
  • In-principle approval from BSE obtained as required
  • Scrutinizer’s report uploaded on BSE Listing Centre 3 working days before record date
  • Compliance with SEBI circular timelines mandatory

Important Dates

  • November 16, 2025: Record date intimation filed
  • November 17, 2025: Bonus issue details and undertaking submitted to BSE
  • December 1, 2025: Deemed date of allotment (T+1 day), bonus shares to be credited by 12:00 PM
  • December 2, 2025: Effective listing date and trading commencement (T+2 day)

Impact Assessment

Shareholder Impact: Existing shareholders will receive 2 bonus shares for every 1 share held as on the record date, tripling their shareholding without additional investment. The face value per share remains ₹10.

Market Impact: The issuance of 10.61 crore bonus shares will triple the issued share capital. While the total market capitalization remains unchanged, the per-share price will adjust proportionately downward, improving liquidity and accessibility for retail investors.

Trading Impact: Shares will be available for trading from December 2, 2025. Investors should expect price adjustment to reflect the 2:1 bonus ratio. The increased float may enhance trading volumes and market depth for Thyrocare Technologies Limited stock.

Impact Justification

Corporate action with 2:1 bonus ratio affecting 10.61 crore shares, significant for existing shareholders and market capitalization adjustment